Disposition kinetics, bioavailability and renal clearance of cefepime in calves
- PMID: 15727293
- DOI: 10.1023/b:verc.0000046738.52788.3c
Disposition kinetics, bioavailability and renal clearance of cefepime in calves
Abstract
The pharmacokinetics of cefepime were studied following intravenous and intramuscular administration of 6.5 mg/kg in four female Friesian calves. Following single intravenous administration, the serum concentration-time curves of cefepime were best fitted using a two-compartment open model. The elimination half-life (t(1/2)beta) was 2.38+/-0.16 h, volume of distribution at steady state (Vdss) was 0.21 +/- 0.01 L/kg, and total body clearance (ClB) was 1.1 +/- 0.08 ml/min per kg. Following intramuscular administration, the drug was rapidly absorbed with an absorption half-life (t(1/2)ab) of 0.29+/-0.02 h; maximum serum concentration (Cmax) of 21.7 +/- 1.1 microg/ml was attained after (Tmax) 1.1 +/- 0.08 h; and the drug was eliminated with an elimination half-life (t(1/2)el) of 3.02 +/- 0.18 h. The systemic bioavailability (F) after intramuscular administration of cefepime in calves was 95.7% +/- 7.44%. The in vitro serum protein-binding tendency was 10.5-16.7%. Following administration by both routes, the drug was excreted in high concentrations in urine for 24 h post administration.
Similar articles
-
Pharmacokinetics of cefepime administered by i.v. and i.m. routes to ewes.J Vet Pharmacol Ther. 2005 Dec;28(6):499-503. doi: 10.1111/j.1365-2885.2005.00689.x. J Vet Pharmacol Ther. 2005. PMID: 16343281
-
Disposition kinetics of difloxacin after intravenous, intramuscular and subcutaneous administration in calves.Vet Res Commun. 2007 May;31(4):467-76. doi: 10.1007/s11259-006-3464-4. Vet Res Commun. 2007. PMID: 17216308 Clinical Trial.
-
Some pharmacokinetic parameters and dosage regimens for a long-acting formulation of oxytetracycline in 6- to 8-month-old male calves.Vet Res Commun. 1998 Dec;22(8):533-44. doi: 10.1023/a:1006193703979. Vet Res Commun. 1998. PMID: 10066127 Clinical Trial.
-
Pharmacokinetics of cefepime: a review.J Antimicrob Chemother. 1993 Nov;32 Suppl B:103-15. doi: 10.1093/jac/32.suppl_b.103. J Antimicrob Chemother. 1993. PMID: 8150753 Review.
-
Review of the pharmacokinetics of cefepime in children.Pediatr Infect Dis J. 2001 Mar;20(3):337-42. doi: 10.1097/00006454-200103000-00032. Pediatr Infect Dis J. 2001. PMID: 11303847 Review.
Cited by
-
Acute-phase response alters the disposition kinetics of cefepime following intravenous administration to rabbits.Vet Res Commun. 2007 Jan;31(1):67-75. doi: 10.1007/s11259-006-3405-2. Epub 2006 Dec 20. Vet Res Commun. 2007. PMID: 17186405
-
Influence of E. coli lipopolysaccharide induced fever on the plasma kinetics of cefepime in cross-bred calves.Vet Res Commun. 2008 Feb;32(2):123-30. doi: 10.1007/s11259-007-9010-1. Epub 2007 Jul 3. Vet Res Commun. 2008. PMID: 17610035 Clinical Trial.
-
Influence of flunixin on the disposition kinetic of cefepime in goats.Adv Pharmacol Sci. 2014;2014:471517. doi: 10.1155/2014/471517. Epub 2014 May 5. Adv Pharmacol Sci. 2014. PMID: 24883058 Free PMC article.
-
Influence of endotoxin induced fever on the pharmacokinetics of intramuscularly administered cefepime in rabbits.J Vet Sci. 2006 Jun;7(2):151-5. doi: 10.4142/jvs.2006.7.2.151. J Vet Sci. 2006. PMID: 16645340 Free PMC article.
-
Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animals.BMC Vet Res. 2016 Sep 6;12(1):185. doi: 10.1186/s12917-016-0817-2. BMC Vet Res. 2016. PMID: 27596044 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical